INVITATION
We invite you to the MVA R&D Network Meeting
on the 9th April in Malmö.
Nanomedicine is defined as nanotechnology embedded in medical applications ultimately for diagnosing and/or treatment of patients. Nanotechnology is a cutting-edge advancement within science and engineering. It is not a single field but an intense collaboration between disciplines to manipulate materials on the atomic and molecular level. When this technology is applied to medicine, the results are especially exciting, and can better our lives in drastic new ways. Its inventive and interdisciplinary nature constantly surprises us, as do the men and women behind these projects.
In this meeting we will listen to inspiring presentations about various applications within Nanomedicine from seven different experts.
Date: Tuesday 9th April 2024
Time: 14:30 – 18:30
Venue: Malmö University, Niagara, Hörsal B1, Nordenskiöldsgatan 1, Malmö, Sverige
Program
14:30
Arrival, registration and network
15:00
Welcome and introduction
Anette Steenberg, CEO, Medicon Valley Alliance
15:05
Title TBA
Jens Viktor Nørgaard, Partner, European Patent Attorney, Høiberg
15:15
High definition brain stimulation (HDBS) – powerful treatments with minimal side effects
Jens Schouenborg, Director, Neuronano Research Center, Lund University
15:30
Enterprise structure enabling translation of academic research into innovative diagnostics
Agnetha Richter Dahlfors, Director, Center for the Advancement of Integrated Medical and Engineering Sciences, KTH, KI
15:45
Inhalable porous particles demonstrating efficient lung drug delivery for antibiotic and protein drugs
Sabrina Valetti, Associate senior lecturer, Malmö University
16:00
SERS-based Detection for Therapeutic Drug Monitoring
Yaman Göksel, CEO, Fluilux Diagnostics and Postdoctoral Researcher, Technical University of Denmark
16:15
Coffee break and networking
16:45
Patches for buccal peptide delivery
Line Hager Nielsen, Associate Professor, Drug Delivery and Sensing, DTU Health Tech
17:00
Delivery of Nucleic Acid Therapeutics using Lipid Nanoparticles
Gustav Emilsson, Senior Scientist, AstraZeneca
17:15
Nanoimprint lithography based antimicrobial surfaces and real-time monitoring of bacterial adhesion
Vladislav Genevskiy, Industrial Ph.D. candidate, Obducat Technologies AB and Malmö University
17:30
Round-up and Networking with light snacks
18:30
End of Meeting
